Publicacións en colaboración con investigadores/as de Hospital Universitario Príncipe de Asturias (3)

2021

  1. Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group

    BMC Cancer, Vol. 21, Núm. 1

2019

  1. SEOM clinical guidelines to primary prevention of cancer (2018)

    Clinical and Translational Oncology, Vol. 21, Núm. 1, pp. 106-113

2010

  1. Adjuvant docetaxel for high-risk, node-negative breast cancer

    New England Journal of Medicine, Vol. 363, Núm. 23, pp. 2200-2210